Ophthal

Your Article Summary

See Latest Articles

Ultrasound assessment of short-term ocular vascular effects of intravitreal injection of bevacizumab (Avastin) in neovascular age-related macular degeneration
Acta Ophthalmologica, 06/29/09

Bonnin P et al. - Intravitreal bevacizumab acutely improved VA and reduced central macular thickness in wet AMD. Ultrasound imaging revealed that BFVs decreased in all retrobulbar arteries, suggesting that after local diffusion, bevacizumab exerts a short-term regional effect. Bevacizumab might therefore induce hypoperfusion of the whole eye, which may correspond to a vascular side-effect.

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Patients' preferences for positioning during phaco-emulsification under topical-intracameral anaesthesia
Clinical and Experimental Ophthalmology, 10/13/09

Five-year Results of a Randomized Trial with Open-label Extension of Triamcinolone Acetonide for Refractory Diabetic Macular Edema
Ophthalmology, 10/05/09

Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
American Journal of Ophthalmology, 10/07/09

See All of Clinical Pharmacology

Today in Retina...keeping you current

Receive free subspecialty "5-minute updates" via email

Five-year Results of a Randomized Trial with Open-label Extension of Triamcinolone Acetonide for Refractory Diabetic Macular Edema
Ophthalmology, 10/05/09

Bevacizumab vs Ranibizumab for Age-related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
American Journal of Ophthalmology, 10/07/09

Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion
Eye, 10/06/09

See All of Retina